Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James J Harding

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Nature|February 14, 2019
Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancersDavid M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Nature|February 9, 2018
HER kinase inhibition in patients with HER2- and HER3-mutant cancersDavid M Hyman, Sarina A Piha-Paul, Helen Won, et al.
JCO Clinical Cancer Informatics|February 24, 2021
OncoTree: A Cancer Classification System for Precision OncologyRitika Kundra, Hongxin Zhang, Robert Sheridan, et al.
Nature Communications|June 19, 2021
Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESSA Rose Brannon, Gowtham Jayakumaran, Monica Diosdado, et al.
Nature Medicine|March 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trialWungki Park, Catherine A O'Connor, Joanne F Chou, et al.
Cell|February 5, 2022
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patientsBastien Nguyen, Christopher Fong, Anisha Luthra, et al.
Nature Medicine|May 9, 2017
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patientsAhmet Zehir, Ryma Benayed, Ronak H Shah, et al.
Nature Medicine|August 5, 2017
Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patientsAhmet Zehir, Ryma Benayed, Ronak H Shah, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Nature|February 14, 2019
Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancersDavid M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Nature|February 9, 2018
HER kinase inhibition in patients with HER2- and HER3-mutant cancersDavid M Hyman, Sarina A Piha-Paul, Helen Won, et al.
JCO Clinical Cancer Informatics|February 24, 2021
OncoTree: A Cancer Classification System for Precision OncologyRitika Kundra, Hongxin Zhang, Robert Sheridan, et al.
Nature Communications|June 19, 2021
Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESSA Rose Brannon, Gowtham Jayakumaran, Monica Diosdado, et al.
Nature Medicine|March 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trialWungki Park, Catherine A O'Connor, Joanne F Chou, et al.
Cell|February 5, 2022
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patientsBastien Nguyen, Christopher Fong, Anisha Luthra, et al.
Nature Medicine|May 9, 2017
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patientsAhmet Zehir, Ryma Benayed, Ronak H Shah, et al.
Nature Medicine|August 5, 2017
Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patientsAhmet Zehir, Ryma Benayed, Ronak H Shah, et al.
Pageof 14